Daniel Abdun-Nabi, CEO at Emergent BioSolutions Inc. (EBS), sold 90,776 shares at $59.49 ($5.5M) on 2018-09-05, disclosed to the SEC on 2018-09-06.
Scheduled sale ($5.5M) by CEO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $60.54 | 60,000 | $3.6M | 66.5% |
| 2 | $59.49 | 30,776 | $1.8M | 33.5% |
| Total | $60.18 avg | 90,776 | $5.5M | 100% |
| Filing → |
| EBS | SELL | 2018-09-18 | $1.9M | — | Filing → |
| EBS | SELL | 2018-06-07 | $823K | — | Filing → |
| EBS | SELL | 2018-01-04 | $1.0M | — | Filing → |